Charles River Laboratories International (CRL) Long-Term Investments (2010 - 2025)

Charles River Laboratories International (CRL) has reported Long-Term Investments for 9 consecutive years, with $207.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Long-Term Investments fell 5.21% year-over-year to $207.0 million; the TTM figure through Dec 2025 stood at $207.0 million (down 5.21% YoY), while the FY2025 annual figure was $207.0 million, down 5.21% from the prior year.
• Long-Term Investments came in at $207.0 million for Q4 2025 at Charles River Laboratories International, up from $194.6 million in the prior quarter.
• The five-year high for Long-Term Investments was $218.4 million in Q4 2024, with the low at $60.6 million in Q1 2022.
• Average Long-Term Investments over 5 years is $158.1 million, with a median of $158.6 million recorded in 2022.
• Across the five-year window, Long-Term Investments soared 189.5% in 2023 and plunged 37.25% in 2024, its largest moves.
• Year by year, Long-Term Investments stood at $149.6 million in 2021, then rose by 22.02% to $182.6 million in 2022, then plunged by 32.83% to $122.7 million in 2023, then surged by 78.02% to $218.4 million in 2024, then decreased by 5.21% to $207.0 million in 2025.
• According to Business Quant data, Long-Term Investments over the past three periods registered $207.0 million, $194.6 million, and $216.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.